연구동향 분석

Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy

송한솔 최원복 송준섭 황일태 양승 2014년

논문상세정보
인용/피인용
' Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 부인과, 산과학, 소아과학
  • bodyheight
  • insulin-like growth factor i
  • precocious puberty
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
520 0

0.0%

' Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy' 의 참고문헌

  • 성선자극호르몬방출호르몬 유도체 치료를 받는 진성성조숙증 여아의 1년간 IGF-1, IGFBP-3 혈중농도의 변화
    이경희 Annals of Pediatirc Endocrinology & Metabolism 16 1 20-23 [2011]
  • Williams textbook of endocrinology
    Grumba ch MM 1509-625 [1998]
  • Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty
    Crowley WF Jr J Clin Endocrinol Metab 52 370-372 [1981]
  • The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency:evidence for a direct role of sex steroids
    Attie KM J Clin Endocrinol Metab 71 975-983 [1990]
  • The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty
    DiMartino-Nardi J J Clin Endocrinol Metab 73 902-906 [1991]
  • The LMS method for constructing normalized growth standards
    Cole TJ Eur J Clin Nutr 44 45-60 [1990]
  • Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion
    Sklar CA J Clin Endocrinol Metab 73 734-738 [1991]
  • Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist
    Harris DA J Clin Endocrinol Metab 61 152-159 [1985]
  • Serum IGF-I during treatment of three different types of abnormal puberty, possible role of IGF-I in pubertal maturation
    Belgorosky A - [1994]
  • Sequential comparisons of onemonth and three-month depot leuprolide regimens in central precocious puberty
    Badaru A J Clin Endocrinol Metab 91 1826-1867 [2006]
  • Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents
    Hyun SE Clin Biochem 45 16-21 [2012]
  • Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years
    Cassio A Arch Dis Child 81 329-332 [1999]
  • Radiographic atlas of skeletal development of hand wrist
    Greulich WW - [1971]
  • Quantitative histomorphometric analysis of the human growth plate from birth to adolescence
    Byers S Bone 27 495-501 [2000]
  • Predicting the adult height of girls with central precocious puberty
    Allali S Med Sci Monit 17 PH41-PH48 [2011]
  • Precocious puberty and statural growth
    Carel JC Hum Reprod Update 10 135-147 [2004]
  • Management and outcome of central precocious puberty
    Partsch CJ Clin Endocrinol 56 129-148 [2002]
  • Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years
    Paul D J Clin Endocrinol Metab 80 546-551 [1995]
  • Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized longterm pilot study
    Bouvattier C J Clin Endocrinol Metab 84 3575-3578 [1999]
  • Insulinlike growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty
    Kanety H Clin Endocrinol 45 7-12 [1996]
  • Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty
    Cara JF J Pediatr 115 64-68 [1989]
  • Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
    김한결 Annals of Laboratory Medicine 31 4 244-249 [2011]
  • Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method
    Kauli R Horm Res 47 54-61 [1997]
  • Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment
    Adan L Clin Endocrinol 56 297-302 [2002]
  • Effects of estrogen on growth plate senescence and epiphyseal fusion
    Weise M Proc Natl Acad Sci USA 98 6871-6876 [2001]
  • Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
    이승재 전남의대학술지 48 1 27-31 [2012]
  • Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty
    Mogensen SS J Clin Endocrinol Metab 96 1393-1401 [2011]
  • Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty
    Weise M J Clin Endocrinol Metab 89 103-107 [2004]
  • Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities
    Chalumeau M Pediatrics 109 61-67 [2002]
  • Adult height in precocious puberty after longterm treatment with deslorelin
    Oerter KE J Clin Endocrinol Metab 73 1235-1240 [1991]
  • 2007 Korean children and adolescents growth standard (commentary for the development of 2007 growth chart)